Akso Health Group
AHG
$1.620 -2.99%
Exchange: NASDAQ | Sector: Financial Services | Industry: Financial Credit Services
Q3 2024
Published: Dec 31, 2023

Earnings Highlights

  • Revenue of $0.76M up 14.8% year-over-year
  • EPS of $-0.13 increased by 85.9% from previous year
  • Gross margin of 5.5%
  • Net income of -3.00M
  • "Transcript not provided in the supplied data." - N/A

Akso Health Group (AHG) QQ3 2024 Earnings Analysis: Revenue Growth Amid Profitability Headwinds in China’s Financial Services Ecosystem

Executive Summary

AHG reported a quarterly revenue of 760,377 (USD thousands) for QQ3 2024, indicating a year-over-year growth of 14.8% and a substantial quarterly uptick of 70.2%. Despite top-line momentum, the company posted an operating loss of 3,161,096 and a net loss of 2,997,405 for the quarter, with gross profit of 41,651 and a thin gross margin of 5.48%. The divergence between revenue growth and profitability is driven by elevated operating expenses, notably General and Administrative spend of 3,118,537 and Selling/SG&A of 3,202,747, resulting in a material operating margin of -4.16%. Net income finished at -2,997,405 with an EPS of -0.14. On the liquidity side, AHG generated positive operating cash flow of 554,452, while investing activity consumed 28,125,000 and financing activity contributed 65,651,849, yielding a net cash increase that left cash at period end at 37,352,416. The balance sheet shows a strong asset base (Total Assets 142,018,117) and an unusually large stockholders’ equity position (138,367,384) with a modest debt footprint (Short-term debt 2,000,000; Net debt negative 83,174,017). The company nonetheless carries a negative earnings trajectory in the near term, implying a cash-funded liquidity runway but a clear need to translate cash into sustainable earnings. The lack of available transcripts in the provided data limits management-quote attribution, constraining qualitative insights from the earnings call. This report therefore emphasizes quantitative trends while outlining plausible qualitative implications based on the disclosed figures and industry context.

Key Performance Indicators

Revenue

760.38K
QoQ: 70.19% | YoY:14.82%

Gross Profit

41.65K
5.48% margin
QoQ: 114.53% | YoY:-41.79%

Operating Income

-3.16M
QoQ: -173.00% | YoY:54.99%

Net Income

-3.00M
QoQ: -95.64% | YoY:59.57%

EPS

-0.14
QoQ: 30.00% | YoY:85.86%

Revenue Trend

Margin Analysis

Key Insights

  • Revenue (QQ3 2024): 760,377; YoY: +14.82%; QoQ: +70.19%
  • Gross Profit: 41,651; Gross Margin: 5.48% (0.0548)
  • Operating Income: -3,161,096; Operating Margin: -4.16%
  • Net Income: -2,997,405; Net Margin: -3.94%
  • EPS: -0.14; Diluted EPS: -0.13; YoY EPS change: +85.86%; QoQ change: +30.00%

Historical Earnings Comparison

PeriodRevenue ($M)EPS ($)YoY GrowthReport
Q4 2024 0.76 -0.13 +14.8% View
Q3 2024 0.76 -0.13 +14.8% View
Q2 2024 0.45 -0.20 -92.5% View
Q1 2024 0.45 -0.20 -92.5% View
Q4 2023 0.66 -0.96 -92.5% View